Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by. At this time, we'd like to welcome everyone to the SciTech Biosciences Second Quarter 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speakers remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, again, press the star one. I would now like to turn the conference over to Paul Kudson, Investor Relations. You may begin. Thank you, operator. Earlier today, SciTech Biosciences released financial results for the second quarter into June 30th, 2025. If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an email to investorsatscitechbio.com. A copy of the news release is also available on the Investor Relations section of SciTech's website at .scitechbio.com. Joining me today from SciTech are Wim Ben-Jong, CEO, and Bill McComb, CFO. Please note that we will be referencing a slide presentation during the call today that has been posted to the Investor section of our corporate website. As a reminder, we will make statements during this call that are forward-looking statements within the meaning of the federal securities laws, including statements regarding SciTech's business plans, strategies, opportunities, and financial projections. These statements are based on the company's current expectations and inherently involve significant risks and uncertainties that could cause actual results or events to materially differ from those anticipated in these statements. Additional information regarding these risks and uncertainties appears in our...